AU3642795A
(en )
1996-04-19
Endothelin receptor antagonists for the treatment of emesis
HU9601529D0
(en )
1996-07-29
Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives as alpha-adrenerg receptor antagonists
EP0676959A4
(en )
1996-01-03
Endothelin receptor antagonists.
HU9603525D0
(en )
1997-02-28
Vironectin receptor antagonists
ZA9610854B
(en )
1998-04-02
Vitronectin receptor antagonists.
ZA968957B
(en )
1998-04-24
Process for the preparation of dihaloazolopyrimidines.
ZA9610859B
(en )
1997-10-24
Vitronectin receptor antagonists.
PL336290A1
(en )
2000-06-19
Sulphonamides for treating endothelin-involving disorders
ZA9610855B
(en )
1997-11-24
Vitronectin receptor antagonists.
ZA9711090B
(en )
1998-06-15
Process for the preparation of hydrocarbons.
ZA969775B
(en )
1998-05-21
Endothelin receptor antagonists.
HU9600256D0
(en )
1996-03-28
Substituted diphenyl-sulfonamides, antagonists of endothelin
ZA9710322B
(en )
1998-06-10
Process for the preparation of benzyl-ethers.
DE69628446D1
(en )
2003-07-03
Polycarbonatharz, vernetztes polycarbonatharz und elektrophotographischer photorezeptor
HU9601176D0
(en )
1996-06-28
Adhesion-receptor antagonists
ZA952587B
(en )
1996-11-27
Human tumor necrosis factor receptor
EP0853629A4
(en )
2001-08-08
Hepadnavirus receptor
ZA973209B
(en )
1997-11-20
Therapeutic compounds.
EP0666851A4
(en )
1995-08-30
Substituted phthalazinones as nerotensin antagonists.
GB9517098D0
(en )
1995-10-25
Receptor
AU7059296A
(en )
1997-05-15
NK-1 receptor antagonists for the treatment of cancer
ZA974811B
(en )
1997-12-30
Novel therapeutic compounds.
ZA979151B
(en )
1998-05-11
Pyrazolinones for treating impaired potency.
ZA965494B
(en )
1997-12-29
Therapeutic agents.
ZA966552B
(en )
1997-02-18
Endothelin receptor antagonists.